Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review. [PDF]
, 2022 PURPOSE The intention of this systematic review was to analyze the literature on breast cancer (BC) and the use of the levonorgestrel-releasing intrauterine system (LNG-IUS).
Janka, Heidrun +3 more
core +1 more source
Intrauterine Device Training Workshop for Preclinical Medical Students [PDF]
MedEdPORTAL, 2019 Medical school reproductive health curricula often lack adequate education regarding intrauterine devices (IUDs). When placed in clinical scenarios, students may have insufficient knowledge and training to counsel patients about IUDs.We developed a workshop for preclinical medical students and assessed whether it improved knowledge of and comfort with ...
Carlie Field +3 more
openaire +3 more sources
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion
Obstetrics & Gynecology, 2022 OBJECTIVE: To explore to what extent intrauterine device (IUD) expulsion is associated with demographic and clinical risk factors. METHODS: The APEX-IUD (Association of Perforation and Expulsion of IntraUterine Devices) study was a U.S.
Anthony, Mary S. +27 more
openaire +2 more sources
Medications to ease intrauterine device insertion: a systematic review [PDF]
Contraception, 2016 Potential barriers to intrauterine device (IUD) use include provider concern about difficult insertion, particularly for nulliparous women.This study aims to evaluate the evidence on the effectiveness of medications to ease IUD insertion on provider outcomes (i.e., ease of insertion, need for adjunctive insertion measures, insertion success).We ...
Lauren B. Zapata +3 more
openaire +2 more sources
Intrauterine devices and risk of uterine perforation: current perspectives [PDF]
, 2016 Uterine perforation is an uncommon complication of intrauterine device insertion, with an incidence of one in 1,000 insertions. Perforation may be complete, with the device totally in the abdominal cavity, or partial, with the device to varying degrees ...
Horwell, D.H., Oloto, E., Rowlands, Sam
core +2 more sources
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology [PDF]
, 2020 n/
Anna Maria Paoletti +13 more
core +3 more sources
Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel [PDF]
, 2016 A matrix-type silicone elastomer vaginal ring providing 28-day continuous release of dapivirine (DPV) - a lead candidate human immunodeficiency virus type 1 (HIV-1) microbicide compound - has recently demonstrated moderate levels of protection in two ...
Blanda, Wendy +10 more
core +1 more source
Thirty years of mirena : A story of innovation and change in women's healthcare [PDF]
, 2021 Since its introduction in 1990, the levonorgestrel-releasing intrauterine system (LNG-IUS) has played a key role in shaping the healthcare landscape of women. Here we explore the development of the first LNG-IUS (Mirena (R)) and the early clinical trials
Caetano, Cecilia +5 more
core +1 more source
Digital Medical Device Companion (MyIUS) for New Users of Intrauterine Systems: App Development Study [PDF]
JMIR Medical Informatics, 2021 Background Women choosing a levonorgestrel-releasing intrauterine system may experience changes in their menstrual bleeding pattern during the first months following placement. Objective Although health care professionals (HCPs) can ...
Toeresin Karakoyun +7 more
openaire +3 more sources
Postpartum contraception: A matter of guidelines [PDF]
, 2023 : The postpartum period is the perfect time to access family planning services. WHO guidelines contraindicate combined hormonal contraceptives postpartum in breastfeeding patients between 6 weeks and 6 months after delivery (Medical Eligibility Criteria ...
Del Savio, Maria C +3 more
core +1 more source